General MedicationsINJECTIONStandard
PROCHLORPERAZINE EDISYLATE
PROCHLORPERAZINE EDISYLATE
Standard Dose
EQ 5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PROCHLORPERAZINE EDISYLATE is listed in Drugs@FDA under application 214379 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PROCHLORPERAZINE EDISYLATE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor CAPLIN Submission history Latest submission status date: 2025-01-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROCHLORPERAZINE EDISYLATE is listed in Drugs@FDA under application 214379 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PROCHLORPERAZINE EDISYLATE Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor CAPLIN Submission history Latest submission status date: 2025-01-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.